Richard Scott Struthers

CRNX

Richard Scott Struthers serves as director, officer: President & CEO at Crinetics Pharmaceuticals, Inc. (CRNX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

14 trades

$22.73M

Net Position

Net Seller

$22.73M

Companies Traded

CRNX

Active Period

Sep 2021 – Mar 2026

14 total trades

Most Recent

Sell CRNX

Mar 18, 2026 · $821.5K

Richard Scott Struthers's Insider Trading at Crinetics Pharmaceuticals, Inc. (CRNX)

Buys

0 · $0.00

Sells

14 · $22.73M

Total Shares Bought

Total Shares Sold

689,033

CRNX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 18, 2026	Sell	21,981	$37.37	$821.5K	413,563
Sep 26, 2025	Sell	4,000	$45.00	$180.0K	0
Mar 19, 2025	Sell	17,338	$34.20	$593.0K	0
Dec 2, 2024	Sell	10,000	$57.57	$575.7K	0
May 8, 2024	Sell	107,448	$49.40	$5.31M	0
Apr 4, 2024	Sell	40,951	$49.17	$2.01M	0
Mar 18, 2024	Sell	12,687	$38.14	$483.9K	0
Nov 2, 2023	Sell	200,000	$30.56	$6.11M	0
Jul 11, 2023	Sell	50,000	$20.21	$1.01M	0
Jun 16, 2023	Sell	50,000	$20.81	$1.04M	0
Mar 16, 2023	Sell	4,628	$17.12	$79.2K	0
Apr 13, 2022	Sell	138,643	$26.83	$3.72M	0
Apr 5, 2022	Sell	21,357	$25.34	$541.2K	0
Sep 7, 2021	Sell	10,000	$25.00	$250.0K	0